{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:16:17Z","timestamp":1789496177491,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejmech.2025.117585","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:27:51Z","timestamp":1743740871000},"page":"117585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel sodium\u2013hydrogen exchanger 1 inhibitors with diphenyl ketone scaffold: Design, Synthesis, mechanism and evaluation in mice model of heart failure"],"prefix":"10.1016","volume":"291","author":[{"given":"Meng","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117585_bib1","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American heart association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2025.117585_bib2","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Disease","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117585_bib3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ejmech.2025.117585_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/j.2040-4603.2016.tb00669.x","article-title":"Pathophysiology of heart failure","volume":"6","author":"Tanai","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.ejmech.2025.117585_bib5","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117585_bib6","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(03)13501-5","article-title":"Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study","volume":"361","author":"Jong","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117585_bib7","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/eurheartj\/ehu164","article-title":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study","volume":"35","author":"Montalescot","year":"2014","journal-title":"Eur. Heart J."},{"issue":"2018","key":"10.1016\/j.ejmech.2025.117585_bib8","first-page":"119","volume":"39","author":"Ibanez","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejmech.2025.117585_bib9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ejhf.1673","article-title":"European Society of Cardiology\/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failure","volume":"22","author":"Seferovic","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejmech.2025.117585_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ejhf.1170","article-title":"Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Seferovic","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejmech.2025.117585_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0008-6363(97)00200-9","article-title":"The Na-H exchanger revisited: an update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease","volume":"36","author":"Frolich","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejmech.2025.117585_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1152\/physrev.1997.77.1.51","article-title":"Molecular physiology of vertebrate Na+\/H+ exchangers","volume":"77","author":"Wakabayashi","year":"1997","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2025.117585_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1527-3466.2007.00010.x","article-title":"Regulation and role of the presynaptic and myocardial Na+\/H+ exchanger NHE1: effects on the sympathetic nervous system in heart failure","volume":"25","author":"Leineweber","year":"2007","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.ejmech.2025.117585_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00788905","article-title":"The role of Na+\/H+ exchange in ischemia-reperfusion","volume":"91","author":"Piper","year":"1996","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejmech.2025.117585_bib15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/j.1552-4604.1998.tb04383.x","article-title":"Sodium ion\/hydrogen ion exchange inhibition: a new pharmacologic approach to myocardial ischemia and reperfusion injury","volume":"38","author":"Levitsky","year":"1998","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117585_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.RES.85.9.777","article-title":"The myocardial Na(+)-H(+) exchange: structure, regulation, and its role in heart disease","volume":"85","author":"Karmazyn","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2025.117585_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardiores.2004.09.024","article-title":"Chronic inhibition of Na+\/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure","volume":"65","author":"Baartscheer","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejmech.2025.117585_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.hipert.2019.09.002","article-title":"Na(+)\/H(+) exchanger and cardiac hypertrophy","volume":"37","author":"Yeves","year":"2020","journal-title":"Hipertens. Riesgo Vasc."},{"key":"10.1016\/j.ejmech.2025.117585_bib19","first-page":"315","article-title":"Amiloride and the Na(+)\/H(+) exchanger protein: mechanism and significance of inhibition of the Na(+)\/H(+) exchanger","volume":"3","author":"Harris","year":"1999","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117585_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104999","article-title":"Rimeporide as a fi rst- in-class NHE-1 inhibitor: results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy","volume":"159","author":"Previtali","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117585_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2302\/kjm.47.65","article-title":"The myocardial sodium-hydrogen exchanger (NHE) and its role in mediating ischemic and reperfusion injury","volume":"47","author":"Karmazyn","year":"1998","journal-title":"Keio J. Med."},{"key":"10.1016\/j.ejmech.2025.117585_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1527-3466.2003.tb00103.x","article-title":"Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1)","volume":"21","author":"Tracey","year":"2003","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.ejmech.2025.117585_bib23","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/s41401-022-00885-8","article-title":"Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1\/MAPK signaling","volume":"43","author":"Lin","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117585_bib24","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jacbts.2019.10.005","article-title":"Empagliflozin and HFrEF: known and possible benefits of NHE1 inhibition","volume":"4","author":"Jun","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.ejmech.2025.117585_bib25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s10517-021-05059-w","article-title":"Effects of zoniporide and BMA-1321 compound on the rate of oxygen absorption by cardiomyocyte mitochondria in rats with experimental chronic heart failure","volume":"170","author":"Spasov","year":"2021","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.117585_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110708","article-title":"Type II diabetes mellitus: a review on recent drug based therapeutics","volume":"131","author":"Padhi","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117585_bib27","article-title":"2024 update in heart failure","author":"Beghini","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ejmech.2025.117585_bib28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s13238-020-00809-4","article-title":"Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis","volume":"13","author":"Jiang","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.ejmech.2025.117585_bib29","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/jm701272q","article-title":"Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes","volume":"51","author":"Meng","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117585_bib30","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s11030-023-10684-w","article-title":"Network pharmacology, molecular docking, and molecular dynamics simulation to elucidate the mechanism of anti-aging action of Tinospora cordifolia","volume":"28","author":"Bisht","year":"2024","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2025.117585_bib31","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.apsb.2022.08.023","article-title":"Structural repurposing of SGLT2 inhibitor empagliflozin for strengthen ing anti-heart failure activity with lower glycosuria","volume":"13","author":"Xu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117585_bib32","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1161\/01.CIR.0000093277.20968.C7","article-title":"Cariporide (HOE642), a selective Na(+)\/H(+) exchange inhibitor, inhibits the mitochondrial death pathway","volume":"108","author":"Teshima","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2025.117585_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2024.104944","article-title":"Pathobiology of myocardial and cardiomyocyte injury in ischemic heart disease: perspective from seventy years of cell injury research","volume":"140","author":"Buja","year":"2024","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ejmech.2025.117585_bib34","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1021\/acsbiomaterials.0c01197","article-title":"Ischemia reperfusion injury: opportunities for nanoparticles","volume":"6","author":"Zang","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.ejmech.2025.117585_bib35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.RES.0000261924.76669.36","article-title":"Distinct roles of autophagy in the heart during ischemia and reperfusi on: roles of AMP-activated protein kinase and Beclin 1 in mediating au tophagy","volume":"100","author":"Matsui","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2025.117585_bib36","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/cvr\/cvad009","article-title":"Empagliflozin inhibits excessive autophagy through the AMPK\/GSK3\u03b2 signalling pathway in diabetic cardiomyopathy","volume":"119","author":"Madonna","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejmech.2025.117585_bib37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbagen.2012.02.010","article-title":"High glucose-induced Ca2+ overload and oxidative stress contribute to apoptosis of cardiac cells through mitochondrial dependent and indepen dent pathways","volume":"1820","author":"Kumar","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2025.117585_bib38","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejmech.2025.117585_bib39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejmech.2025.117585_bib40","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1006\/jmcc.1998.0741","article-title":"Regional myocyte hypertrophy parallels regional myocardial dysfunction during post-infarct remodeling","volume":"30","author":"Kramer","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejmech.2025.117585_bib41","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/CIRCULATIONAHA.119.044313","article-title":"Neuregulin-1 induces cardiac hypertrophy and impairs cardiac performan ce in post-myocardial infarction rats","volume":"142","author":"Zurek","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2025.117585_bib42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9149(02)03414-8","article-title":"Early Afterload Reducing Therapy Trial, Left ventricular hypertrophy and the risk of subsequent left ventricul ar remodeling following myocardial infarction","volume":"91","author":"Jilaihawi","year":"2003","journal-title":"Am. J. Cardiol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:44:31Z","timestamp":1778042671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425003502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":42,"alternative-id":["S0223523425003502"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117585","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel sodium\u2013hydrogen exchanger 1 inhibitors with diphenyl ketone scaffold: Design, Synthesis, mechanism and evaluation in mice model of heart failure","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117585"}}